Program diagnostic forms

Use these forms to submit clinical information to the National Cancer Screening Register.

Table 1. Bowel program forms
Form Name When to use this report
NBCSP – Adverse Events Report To be completed by a colonoscopist or other healthcare provider to report information about an adverse outcome for a procedure relating to diagnostic investigation of a program participant who has received a positive iFOBT result.

This form is only used where that information has not already been included in the Colonoscopy Report.

NBCSP – GP Assessment Report To be completed by a general practitioner to provide information about consultations with program participants who have received a positive iFOBT test result. This supports timely follow-up by the NBCSP along the screening pathway.
NBCSP – Colonoscopy Report To be completed by colonoscopists to report the results of a colonoscopy for a program participant with a positive iFOBT result.

This form also enables colonoscopists to report adverse events which may have occurred during the procedure or are known at the time of completing this form.

NBCSP – Histopathology Report To be completed by a histopathologist or a colonoscopist to report the results from testing specimens collected during the colonoscopy procedure for a program participant with a positive iFOBT result.
Table 2. Cervical program forms
Form Name When to use this report
NCSP – Abnormal Result Questionnaire When a program participant has had abnormal cervical screening results, and the NCSR has not received notice that a colposcopy has been performed.

The cervical program will send a letter to the healthcare provider to request this information where applicable.

NCSP – Colposcopy and Treatment Form To be completed by a colposcopist to notify prescribed cervical screening information to inform participant clinical pathways and support the safety net function of the NCSR. It is also used for reporting performance measures for colposcopists.
NCSP – Total Hysterectomy Assessment Form To be completed by healthcare providers to notify the NCSR when a patient has had a total hysterectomy. This will ensure the hysterectomy is accurately reported against their record, and no further invitations and reminders for cervical screening will be sent to them from the NCSR.
Table 3. Lung program forms
Form Name When to use this report
NLCSP – Eligibility & Enrolment Form A Requesting Practitioner completes a low-dose CT scan request for an eligible patient and submits the Eligibility & Enrolment form to initiate the screening journey for their patient.
NLCSP - Participation Management Form Update your patient’s screening status – such as confirming if they should exit the program due to becoming ineligible, opting out or being diagnosed with cancer. If there are changes to their suitability to low-dose CT for their follow-up scan, this can also be updated through this form. Keeping this up to date helps avoid unnecessary follow-ups if they needed to be exited or ensures the register safety net is resumed if they again become suitable for low-dose CT.
NLCSP - Biopsy Adverse Events Form Report any adverse events following a biopsy. This supports patient safety and informs clinical decision-making and contributes to quality and monitoring of the NLCSP.
NLCSP - Specialist Referral Form Notifies the register of patient referral to a respiratory physician or other specialist (i.e. following a Category 5/6 (high-risk) result). Prompt notification will avoid the NCSR contacting you to seek information to ensure your patient is getting a timely diagnosis.
NLCSP - Diagnosis Form Record confirmed diagnostic findings after a low-dose CT scan. Accurate reporting supports future screening decisions such as whether to exclude or continue screening, timely care, and national reporting and quality improvement.
NLCSP - Radiology Report Used to submit low-dose CT scan results, including provider details, nodule findings, and screening category, to support clinical follow-up, program monitoring, and appropriate patient management.